Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Clinical genomics expands the morbid genome of intellectual disability and offers a high diagnostic yield

Abstract

Intellectual disability (ID) is a measurable phenotypic consequence of genetic and environmental factors. In this study, we prospectively assessed the diagnostic yield of genomic tools (molecular karyotyping, multi-gene panel and exome sequencing) in a cohort of 337 ID subjects as a first-tier test and compared it with a standard clinical evaluation performed in parallel. Standard clinical evaluation suggested a diagnosis in 16% of cases (54/337) but only 70% of these (38/54) were subsequently confirmed. On the other hand, the genomic approach revealed a likely diagnosis in 58% (n=196). These included copy number variants in 14% (n=54, 15% are novel), and point mutations revealed by multi-gene panel and exome sequencing in the remaining 43% (1% were found to have Fragile-X). The identified point mutations were mostly recessive (n=117, 81%), consistent with the high consanguinity of the study cohort, but also X-linked (n=8, 6%) and de novo dominant (n=19, 13%). When applied directly on all cases with negative molecular karyotyping, the diagnostic yield of exome sequencing was 60% (77/129). Exome sequencing also identified likely pathogenic variants in three novel candidate genes (DENND5A, NEMF and DNHD1) each of which harbored independent homozygous mutations in patients with overlapping phenotypes. In addition, exome sequencing revealed de novo and recessive variants in 32 genes (MAMDC2, TUBAL3, CPNE6, KLHL24, USP2, PIP5K1A, UBE4A, TP53TG5, ATOH1, C16ORF90, SLC39A14, TRERF1, RGL1, CDH11, SYDE2, HIRA, FEZF2, PROCA1, PIANP, PLK2, QRFPR, AP3B2, NUDT2, UFC1, BTN3A2, TADA1, ARFGEF3, FAM160B1, ZMYM5, SLC45A1, ARHGAP33 and CAPS2), which we highlight as potential candidates on the basis of several lines of evidence, and one of these genes (SLC39A14) was biallelically inactivated in a potentially treatable form of hypermanganesemia and neurodegeneration. Finally, likely causal variants in previously published candidate genes were identified (ASTN1, HELZ, THOC6, WDR45B, ADRA2B and CLIP1), thus supporting their involvement in ID pathogenesis. Our results expand the morbid genome of ID and support the adoption of genomics as a first-tier test for individuals with ID.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Maulik PK, Harbour CK . Epidemiology of intellectual disability. In: JH Stone, M Blouin (eds). International Encyclopedia of Rehabilitation 2010. Available at: http://cirrie.buffalo.edu/encyclopedia/en/article/144/.

  2. Association AP Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). American Psychiatric Pub 2013.

  3. Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86: 749–764.

    Article  CAS  Google Scholar 

  4. Männik K, Mägi R, Macé A, Cole B, Guyatt AL, Shihab HA et al. Copy number variations and cognitive phenotypes in unselected populations. JAMA 2015; 313: 2044–2054.

    Article  Google Scholar 

  5. Rauch A, Wieczorek D, Graf E, Wieland T, Endele S, Schwarzmayr T et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 2012; 380: 1674–1682.

    Article  CAS  Google Scholar 

  6. de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 2012; 367: 1921–1929.

    Article  CAS  Google Scholar 

  7. Vissers LE, Gilissen C, Veltman JA . Genetic studies in intellectual disability and related disorders. Nat Rev Genet 2016; 17: 9–18.

    Article  CAS  Google Scholar 

  8. Gilissen C, Hehir-Kwa JY, Thung DT, van de Vorst M, van Bon BW, Willemsen MH et al. Genome sequencing identifies major causes of severe intellectual disability. Nature 2014; 511: 344–347.

    Article  CAS  Google Scholar 

  9. Group SM. Comprehensive gene panels provide advantages over clinical exome sequencing for Mendelian diseases. Genome Biol 2015; 16: 134.

    Article  Google Scholar 

  10. Alkuraya FS . Autozygome decoded. Genet Med 2010; 12: 765–771.

    Article  Google Scholar 

  11. Alkuraya FS . The application of next-generation sequencing in the autozygosity mapping of human recessive diseases. Hum Genet 2013; 132: 1197–1211.

    Article  CAS  Google Scholar 

  12. Alkuraya FS . Discovery of mutations for Mendelian disorders. Hum Genet 2016; 135: 1–9.

    Article  Google Scholar 

  13. Al-Qattan SM, Wakil SM, Anazi S, Alazami AM, Patel N, Shaheen R et al. The clinical utility of molecular karyotyping for neurocognitive phenotypes in a consanguineous population. Genet Med 2014; 17: 719–725.

    Article  Google Scholar 

  14. Kearney HM, Thorland EC, Brown KK, Quintero-Rivera F, South ST . American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med 2011; 13: 680–685.

    Article  Google Scholar 

  15. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17: 405–424.

    Article  Google Scholar 

  16. Arnold K, Bordoli L, Kopp J, Schwede T . The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006; 22: 195–201.

    Article  CAS  Google Scholar 

  17. Kallberg M, Margaryan G, Wang S, Ma J, Xu J . RaptorX server: a resource for template-based protein structure modeling. Methods Mol Biol 2014; 1137: 17–27.

    Article  CAS  Google Scholar 

  18. Kall L, Krogh A, Sonnhammer EL . A combined transmembrane topology and signal peptide prediction method. J Mol Biol 2004; 338: 1027–1036.

    Article  CAS  Google Scholar 

  19. Hunter S, Jones P, Mitchell A, Apweiler R, Attwood TK, Bateman A et al. InterPro in 2011: new developments in the family and domain prediction database. Nucleic Acids Res 2012; 40 (Database issue): D306–D312.

    Article  CAS  Google Scholar 

  20. Abouelhoda M, Sobahy T, El-Kalioby M, Patel N, Shamseldin H, Monies D et al. Clinical genomics can facilitate countrywide estimation of autosomal recessive disease burden. Genet Med 2016; e-pub ahead of print.

  21. Le Fevre AK, Taylor S, Malek NH, Horn D, Carr CW, Abdul‐Rahman OA et al. FOXP1 mutations cause intellectual disability and a recognizable phenotype. Am J Med Genet 2013; 161: 3166–3175.

    Article  CAS  Google Scholar 

  22. Paesold-Burda P, Maag C, Troxler H, Foulquier F, Kleinert P, Schnabel S et al. Deficiency in COG5 causes a moderate form of congenital disorders of glycosylation. Hum Mol Genet 2009; 18: 4350–4356.

    Article  CAS  Google Scholar 

  23. Karaca E, Harel T, Pehlivan D, Jhangiani SN, Gambin T, Akdemir ZC et al. Genes that affect brain structure and function identified by rare variant analyses of mendelian neurologic disease. Neuron 2015; 88: 499–513.

    Article  CAS  Google Scholar 

  24. Beaulieu CL, Huang L, Innes AM, Akimenko M-A, Puffenberger EG, Schwartz C et al. Intellectual disability associated with a homozygous missense mutation in THOC6. Orphanet J Rare Dis 2013; 8: 62.

    Article  Google Scholar 

  25. Alazami AM, Patel N, Shamseldin HE, Anazi S, Al-Dosari MS, Alzahrani F et al. Accelerating novel candidate gene discovery in neurogenetic disorders via whole-exome sequencing of prescreened multiplex consanguineous families. Cell Rep 2015; 10: 148–161.

    Article  CAS  Google Scholar 

  26. Larti F, Kahrizi K, Musante L, Hu H, Papari E, Fattahi Z et al. A defect in the CLIP1 gene (CLIP-170) can cause autosomal recessive intellectual disability. Eur J Hum Genet 2015; 23: 331–336.

    Article  CAS  Google Scholar 

  27. Yang Y, Muzny DM, Xia F, Niu Z, Person R, Ding Y et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA 2014; 312: 1870–1879.

    Article  CAS  Google Scholar 

  28. Lee H, Deignan JL, Dorrani N, Strom SP, Kantarci S, Quintero-Rivera F et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA 2014; 312: 1880–1887.

    Article  Google Scholar 

  29. Need AC, Shashi V, Hitomi Y, Schoch K, Shianna KV, McDonald MT et al. Clinical application of exome sequencing in undiagnosed genetic conditions. J Med Genet 2012; 49: 353–361.

    Article  CAS  Google Scholar 

  30. Alkuraya FS . Natural human knockouts and the era of genotype to phenotype. Genome Med 2015; 7: 48.

    Article  Google Scholar 

  31. Shaheen R, Patel N, Shamseldin H, Alzahrani F, Al-Yamany R, ALMoisheer A et al. Accelerating matchmaking of novel dysmorphology syndromes through clinical and genomic characterization of a large cohort. Genet Med 2016; e-pub ahead of print.

  32. Alkuraya FS . Human knockout research: new horizons and opportunities. Trends Genet 2015; 31: 108–115.

    Article  CAS  Google Scholar 

  33. Han C, Daubaras M, McPherson PS . DENND5A regulates NGF-induced neurite outgrowth in PC12 cells and dendrite patterning of primary hippocampal neurons. Int J Dev Neurosci 2015; 47 (Pt A): 116–116.

    Article  Google Scholar 

  34. Long SW, Ooi JY, Yau PM, Jones PL . A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing. Biosci Rep 2011; 31: 333–343.

    Article  CAS  Google Scholar 

  35. Lee KJ, Lee Y, Rozeboom A, Lee J-Y, Udagawa N, Hoe H-S et al. Requirement for Plk2 in orchestrated ras and rap signaling, homeostatic structural plasticity, and memory. Neuron 2011; 69: 957–973.

    Article  CAS  Google Scholar 

  36. Santoro ML, Santos CM, Ota VK, Gadelha A, Stilhano RS, Diana MC et al. Expression profile of neurotransmitter receptor and regulatory genes in the prefrontal cortex of spontaneously hypertensive rats: relevance to neuropsychiatric disorders. Psychiatry Res 2014; 219: 674–679.

    Article  CAS  Google Scholar 

  37. Seong E, Wainer B, Hughes E, Saunders T, Burmeister M, Faundez V . Genetic analysis of the neuronal and ubiquitous AP-3 adaptor complexes reveals divergent functions in brain. Mol Biol Cell 2005; 16: 128–140.

    Article  CAS  Google Scholar 

  38. Ben-Arie N, Bellen HJ, Armstrong DL, McCall AE, Gordadze PR, Guo Q et al. Math1 is essential for genesis of cerebellar granule neurons. Nature 1997; 390: 169–172.

    Article  CAS  Google Scholar 

  39. Reinhard J . The function of Copine 6 in the brain. PhD thesis, University of Basel 2012.

  40. Molyneaux BJ, Arlotta P, Hirata T, Hibi M, Macklis JD . Fezl is required for the birth and specification of corticospinal motor neurons. Neuron 2005; 47: 817–831.

    Article  CAS  Google Scholar 

  41. Chen J-G, Rašin M-R, Kwan KY, Šestan N . Zfp312 is required for subcortical axonal projections and dendritic morphology of deep-layer pyramidal neurons of the cerebral cortex. Proc Natl Acad Sci USA 2005; 102: 17792–17797.

    Article  CAS  Google Scholar 

  42. Chen B, Schaevitz LR, McConnell SK . Fezl regulates the differentiation and axon targeting of layer 5 subcortical projection neurons in cerebral cortex. Proc Natl Acad Sci USA 2005; 102: 17184–17189.

    Article  CAS  Google Scholar 

  43. Wentzel C, Sommer JE, Nair R, Stiefvater A, Sibarita J-B, Scheiffele P . mSYD1A, a mammalian synapse-defective-1 protein, regulates synaptogenic signaling and vesicle docking. Neuron 2013; 78: 1012–1023.

    Article  CAS  Google Scholar 

  44. Hallam SJ, Goncharov A, McEwen J, Baran R, Jin Y . SYD-1, a presynaptic protein with PDZ, C2 and rhoGAP-like domains, specifies axon identity in C. elegans. Nat Neurosci 2002; 5: 1137–1146.

    Article  CAS  Google Scholar 

  45. Owald D, Khorramshahi O, Gupta VK, Banovic D, Depner H, Fouquet W et al. Cooperation of Syd-1 with Neurexin synchronizes pre-with postsynaptic assembly. Nat Neurosci 2012; 15: 1219–1226.

    Article  CAS  Google Scholar 

  46. Laezza F, Wilding TJ, Sequeira S, Coussen F, Zhang XZ, Hill-Robinson R et al. KRIP6: a novel BTB/kelch protein regulating function of kainate receptors. Mol Cell Neurosci 2007; 34: 539–550.

    Article  CAS  Google Scholar 

  47. Schulte JD, Srikanth M, Das S, Zhang J, Lathia JD, Yin L et al. Cadherin-11 regulates motility in normal cortical neural precursors and glioblastoma. PLoS One 2013; 8: e70962.

    Article  CAS  Google Scholar 

  48. Girijashanker K, He L, Soleimani M, Reed JM, Li H, Liu Z et al. Slc39a14 gene encodes ZIP14, a metal/bicarbonate symporter: similarities to the ZIP8 transporter. Mol Pharmacol 2008; 73: 1413–1423.

    Article  CAS  Google Scholar 

  49. Monroe GR, Frederix GW, Savelberg SM, de Vries TI, Duran KJ, van der Smagt JJ et al. Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability. Genet Med 2016; e-pub ahead of print.

Download references

Acknowledgements

We thank the study families for their enthusiastic participation. This work was supported by KACST Grant 13-BIO1113-20 (FSA) and the Saudi Human Genome Project. The research by STA reported in this publication was supported by funding from King Abdullah University of Science and Technology (KAUST).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to R Shaheen or F S Alkuraya.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Molecular Psychiatry website

Supplementary information

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anazi, S., Maddirevula, S., Faqeih, E. et al. Clinical genomics expands the morbid genome of intellectual disability and offers a high diagnostic yield. Mol Psychiatry 22, 615–624 (2017). https://doi.org/10.1038/mp.2016.113

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/mp.2016.113

This article is cited by

Search

Quick links